Matthew Judson is a research associate in the UNC Neuroscience Center at the University of North Carolina at Chapel Hill.
Matthew Judson
Research associate
University of North Carolina at Chapel Hill
From this contributor
Angelman syndrome: Bellwether for genetic therapy in autism
It is not a matter of whether there will be clinical trials of genetic therapy for Angelman syndrome, but when.
Angelman syndrome: Bellwether for genetic therapy in autism
Insights for autism from Angelman syndrome
Deletions or duplications of the UBE3A gene lead to both Angelman syndrome and some cases of autism, respectively. Studying the effects of altered gene dosage in this region will provide insights into brain defects and suggest targets for therapies for both disorders, says expert Benjamin Philpot.
Insights for autism from Angelman syndrome
Explore more from The Transmitter
A brief history of precision self-scanning
When a researcher solved a logistical problem by going rogue, the idea proved remarkably infectious.
A brief history of precision self-scanning
When a researcher solved a logistical problem by going rogue, the idea proved remarkably infectious.
Sensory profiles in autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 19 January.
Sensory profiles in autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 19 January.
Frameshift: At a biotech firm, Ubadah Sabbagh embraces the expansive world outside academia
As chief of staff at Arcadia, Ubadah Sabbagh gets to do science while also pushing the boundaries of how science gets done.
Frameshift: At a biotech firm, Ubadah Sabbagh embraces the expansive world outside academia
As chief of staff at Arcadia, Ubadah Sabbagh gets to do science while also pushing the boundaries of how science gets done.